The development of pressure ulcers in spinal cord injury patients is extremely common, often requiring extensive surgical procedures. Macrophages (MACs) play a crucial role in the innate immune system, contributing to wound healing and overall regeneration. MACs have been found to possess the potential to be activated by external factors from their M0 inactive state to an M1 proinflammatory or M2 regenerative state. This study conducted a comprehensive evaluation of MAC phenotype in response to electrospun scaffolds of varying material fiber/pore diameter, fiber stiffness, and +/− inclusion of platelet-rich plasma (PRP). Generally, it was found that the addition of PRP resulted in decreased pore size, where 5 silk fibroin (SF) had the stiffest fibers. Furthermore, PRP scaffolds demonstrated an increased production of VEGF and chemotaxis. The polycaprolactone (PCL) and SF scaffolds had the largest cell infiltration and proliferation. Overall, it was found that 5% SF had both ideal fiber and pore structure, allowing for cell infiltration further enhanced by the presence of PRP. Additionally, this scaffold led to a reasonable production of VEGF while still allowing fibroblast proliferation to occur. These results suggest that such a scaffold could provide an off-the-shelf product capable of modifying the local MAC response.
Introduction
Macrophages (MACs) are imperative for a proper inflammatory response. Upon infection or in the presence of a wound such as an ulcer or laceration, monocytes differentiate into MACs and enter the tissue. Through phagocytosis, they clear the area of apoptotic cells and any leftover debris. However, MACs do not come in a single form, but instead possess various phenotypes which contribute to the overall wound healing process. Classically activated MACs (M1) are significant for host defense and inducing inflammation while alternatively activated MACs (M2) oppose this process, moving the wound site into the final healing phase [1] . Additionally, the presence of solely M1 MACs has induced increased connective tissue and scarring at the wound site, while sole M2 MAC presence has led to complete wound healing [2] .
External factors can trigger the activation of different phenotypes of the MACs. MAC polarization can be effected by biomaterial fiber and pore size, where increased polymer concentrations lead to the presence of M2 MACs, which in turn lead to wound healing and regeneration [3] . It is also important to note that MACs are not permanently differentiated, but are plastic in that they possess the ability to switch back and forth between M1 and M2 depending upon the local environment [4] [5] [6] .
Over 65% of spinal cord injury patients will develop pressure ulcers [7] . Chronic pressure ulcers are stalled in a state of chronic inflammation, where the presence of M1 phenotype MACs induces substantial neutrophil infiltration. These wounds often require surgical intervention followed by a costly wound treatment regimen. However, this treatment is not ideal, often leading to reopening of the wound through excessive scar formation and contraction [8] . Not only does this negatively impact the patient's quality of life, but also disrupts the health care system and increases patient costs. Currently it is estimated that the treatment of a single wound costs around $70,000, not including absence from work, loss of employment, cost of medical transport, assistance with daily living, and selfcare and medication expenditures. Annually, the United States spends approximately $17 billion treating pressure ulcers [7, 9] . Thus, there exists a clear need for an off-theshelf dermal regeneration template that could potentially modulate the MAC response to promote regeneration.
Electrospinning, a well-known textile fabrication technique, has recently been adapted for scaffold fabrication. With this method, a highly volatile polymeric solution is extruded into a large electric field directed at a grounded mandrel. The volatile solvent evaporates as it moves through the electric field leaving a charged polymer chain. The charge on this chain is attracted to the grounded mandrel where it deposits randomly, creating a web of polymeric nanofibers. A previous study has shown that by varying the diameter of polydioxanone (PDO) electrospun scaffolds, the overall MAC behavior is affected [3] . When larger fiber diameters were used, MAC infiltration and the expression of the M2 phenotype increased. By increasing fiber diameter, pore size increases linearly, allowing for improved infiltration [3] .
For this study gelatin (Gel), polycaprolactone (PCL), and silk fibroin (SF) were chosen based on their physical properties and potential interaction with MACs. Gel is composed of denatured collagen and can be crosslinked to form a matrix that will not dissolve in water. Gel is inexpensive, biodegradable, and has been utilized for electrospun drug delivery, skin, and cardiovascular applications [10] [11] [12] [13] . PCL is a synthetic material commonly used in tissue engineering that is hydrophobic and soluble with modifiable degradation and mechanical properties [14] . PCL electrospun fibers have been used for a variety of applications including skin, vascular, and nerve tissue [15] [16] [17] [18] . SF is a natural and biocompatible polymer proven to possess excellent mechanical properties in comparison to all other natural polymers [19] . Additionally, SF has been previously electrospun to produce fibers with a wide range of diameters, water resistance, and cell compatibility [20] [21] [22] . SF electrospun scaffold applications include vascular, bone, nerve, skin, and wound healing [23] [24] [25] [26] [27] . These three materials have well established properties and will be tailored for an ideal MAC response and a future use in the treatment of chronic pressure ulcers.
Platelet-rich plasma (PRP), has been previously used with some success to treat chronic dermal wounds [28] [29] [30] . Recent research has indicated that lyophilized PRP (i.e. a preparation rich in growth factors, PRGF) may contain a number of MAC phenotype modifying biomolecules (IL-10, lipoxins) [31] [32] [33] . It has been suggested that PRP possesses the ability to modify the local inflammatory response and stimulate healing in chronic pressure ulcers. In a published case report, patients suffering from chronic stage IV pressure ulcers were treated with PRP over a several week time course. The PRP stimulated angiogenesis and healing and promoted closure in all ulcers treated, but with significant scar formation. Healed but scarred ulcers indicate that while the growth factors and cytokines in PRP can accelerate wound closure, a scaffold is necessary to provide structure, support, and to prevent scarring and subsequent wound re-opening [29] .
In this study, electrospun scaffolds of various compositions were doped with PRP to assess the ability of PRP-scaffolds to modulate MAC phenotype in an antiinflammatory manner while providing a structural support similar to native tissue that also allows M2 MAC phenotype modulation. It is hypothesized that adequate regulation of pore size, fiber size, fiber strength, and fiber diameter will allow infiltration and M2 differentiation of neutral M0 MACs. The extension of this project is to be able to use the electrospun PRP product to break the chronic inflammatory cycle and promote tissue regeneration with appropriate cytokines and structural stability. Gel, PCL, and SF electrospun scaffolds were tested in parallel to provide a comprehensive evaluation of MAC phenotype as fiber/pore diameter, fiber stiffness, and the inclusion of PRP. Such a characterization provides further information regarding the creation of an ideal off-the-shelf dermal substitute.
Experimental Procedures

PRP/PRGF Preparation
Adapted from previous studies, briefly, fresh whole human blood from donors was collected, pooled, and centrifuged at 200 g for 20 minutes [34] . The plasma and buffy coat layer were removed and centrifuged again at 1000 g for 10 minutes. At this time, ¾ of the plasma was removed. The remaining plasma was resuspended with the platelet pellet creating PRP, yielding a final platelet count in the range of million/µL. PRP was frozen in a −70 ∘ C freezer overnight. Frozen PRP solution was then lyophilized for 24 hours and ground into a fine powder referred to as a preparation rich in growth factors (PRGF). The PRGF was stored in a −20 ∘ C freezer until use [35] . fibers (n = 60). The average pore area was determined by tracing the outer area of randomly chosen pores (n = 60).
Atomic Force Microscopy (AFM)
During the electrospinning process, a glass slide was briefly held between the needle and collecting mandrel to gather a single layer of fibers of each material type. The fibers were either left dry or hydrated for 15 minutes with deionized (DI) water prior to measurement. An AFM (Bruker Bioscope Catalyst) was used to determine the stiffness of each material's fibers by placing the cantilever with a probe (MLCT-E probe, k = 0.1N/m, fo = 38kHz, tip radius = 20nm, deflection sensitivity = 18.85nm/V) on the sample, scanning the surface, and recording the bending of the cantilever via laser deflection. To obtain images the following parameters were utilized: peak force set point = 200pN (variant for accurate force curves), peak force amplitude = 100nm, scan size = 5 microns (variant depending on fiber size), 0.5 Hz scan rate, 512 samples/line, rounding = 0.15, and z-range = 5 microns.
(2) Biological Characterization of Electrospun Scaffolds Cells in Culture Conditions
Naïve M0 MACs from differentiated human blood monocytes (PBMC, ATCC) were cultured in HyClone's RPMI 1640 Medium (Hyclone, Pennsylvania), 10% fetal bovine serum (FBS) (Biowest, Texas), and 1% penicillin-streptomycin solution (Hyclone, Pennsylvania). Human dermal fibroblasts (hDF, passage 4; ATCC, Virginia) were cultured in serum free DMEM/F-12 media (Lonza, New Jersey) supplemented with 1% penicillin-streptomycin solution (Hyclone, Pennsylvania). Human umbilical vein endothelial cells (HUVEC, passage 3, ATCC) were cultured in Medium 200 supplemented with large vessel endothelial supplement (LVES) (Thermo Fisher Scientific, New York). All cells were cultured in an incubator at 37 ∘ C and 5% CO 2 . Media for all cell types was changed every 2-3 days until the cells were confluent and used for the appropriate study indicated below.
Cellular Infiltration
A 10mm biopsy punch (Acuderm, Inc., Florida) of each scaffold material (n = 6) was ultraviolet (UV) sterilized for one hour on each side. Note that all Gel scaffolds were crosslinked in 17.6 mM 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC, Thermo Fisher Scientific, Massachusetts) dissolved in 70% ethanol for 18 hours at room temperature on a shaker plate. At this time, the scaffolds were rinsed in a 0.1 M sodium phosphate solution for 2 hours prior to sterilization [36] . All SF scaffolds were crosslinked with methanol vapor for one hour [37] . All electrospun scaffolds were placed in a 48 well plate (Falcon, New York) and seeded with a 600 µL cell suspension composed of 50,000 naïve M0 MACs. The scaffolds and the cell conditioned media (CCM), were collected on days 1, 4, and 7. A parallel study was completed without cells, producing scaffold conditioned media (SCM). This was also replicated at a 6-hour time point for angiogenesis testing. All conditioned media was stored at -20 ∘ C for further analysis. Note that all experiments (i.e. VEGF releasate, cellular proliferation, chemotaxis, and angiogenesis) were completed using the release media from this single cell preparation, with different technical replicates. Specifically, six independent scaffolds were used with a single biological replicate for preliminary data. The scaffolds were placed in formalin (Protocol, Michigan) for 24 hours and then a 30% sucrose solution for an additional 24 hours prior to sectioning. All scaffolds were then embedded in Optimal Cutting Temperature (OCT) Compound and frozen at −80 ∘ C for 24 hours. Each sample was cryosectioned at 20 µm and stained with 4',6'-Diamidino-2-phenylindole dihydrochloride (DAPI, 98%, Acros, New Jersey) to observe cellular infiltration over the various time points. Stained sections were imaged using a fluorescent light microscope (Axiovert 200, Zeiss).
Cellular Proliferation
Fibroblasts were exposed to the SCM or CCM from the cellular infiltration study to quantify its effect on cellular proliferation. Briefly, 50,000 hDFs were seeded into a 48 well plate and placed in an incubator for 2 hours to allow for full attachment. After the cells were plated, all media was removed and replaced with 400 µL of conditioned media supplemented with serum free DMEM/F-12 media at a 1:1 ratio to ensure enough nutrient support for cell growth. After 72 hours, the modified media was removed and replaced with 200 µL of serum free DMEM/F-12. An MTS assay (Celltiter 96 Aqueous Non-Radioactive Cell Proliferation Assay, Promega) was performed; where 40 µL of MTS/PMS solution was added to each well and plates were incubated for one hour at 37 ∘ C. 100 µL was removed and read via spectrophotometer (SpectraMax i3) at 490 nm to quantify cell number as affected by each condition.
Chemotaxis
50,000 M0 MACs in 200 µl of complete media were seeded on the top portion of an insert with 8 µm diameter pores in a transwell plate (Corning, Massachusetts). 500 µl of SCM from the cellular infiltration study was placed in the bottom well. The transwell assay was incubated under standard culture conditions for 72 hours and an MTS assay was used to determine cell number in both the insert and bottom well, quantifying chemotaxis from the seeded transwell to the SCM-doped bottom well.
VEGF Releasate
25 µL of SCM or CCM mentioned previously was analyzed via multiplexer (Luminex MagPix) with a human cytokine/chemokine magnetic bead panel (MILLIPLEX ® MAP) and a human VEGF Quantikine® ELISA (R&D Systems) to detect quantities of VEGF. Increased concentration of VEGF is considered indicative of an M2 change in phenotype. DMEM/F12 media, with or without cells, were used as controls. Note that only VEGF data is provided as this was the only cytokine/chemokine with detectable levels and is an appropriate representation of the macrophage phenotype. 
Angiogenesis
An in vitro angiogenesis assay (Gibco, Angiogenesis Starter Kit) was performed using stored media from the 6-hour cell infiltration study. The protocol provided within the assay was followed in order to quantify tube formation. 25,000 HUVECs were seeded on a 48-well plate coated with Geltrex (LDEV-free reduced growth factor basement membrane matrix, Thermo Fisher Scientific, New York). SCM or CCM in 125 µL volumes and 125 µL of the LVES Supplemented Media 200 was added to each well; images were obtained after 24 hours. Tubules in each well were counted and analyzed using WimTube (Wimasis Image Analysis, Spain) and images were merged using ImageJ (NIH). Light and DAPI images were opened within the program and the channels were merged such that the fluorescent image was selected in the blue channel and the light image in the gray channel. At this time the composite image was created and saved as RGB color.
Statistics
Statistical analysis was performed on all groups using a Kruskal-Wallis one-way analysis of variance with IBM SPSS software. Results were considered significant with p-values less than 0.05 and the standard deviation is reported in all graphs. Figure 2B ); 10 Gel (+/− PRGF), 5 PCL, 15 PCL, and 10 SF PRGF pore diameters were also all significantly larger than 10 SF (p<0.05). With increasing concentrations of polymer, the fiber diameter increased, as is consistent with published literature [38] [39] [40] . Pore area increased in the non-PRGF scaffolds with increasing concentrations, which is also consistently noted, as fiber hindrance is increased with larger fibers. Inclusion of the PRGF appears to have very little effect on the fiber diameter, but moderately decreased the pore area. While the incorporation of PRGF did not affect the fiber diameter, it did decrease the pore area in all PCL scaffolds, 5 SF, and 10 Gel. Decreased pore area with the addition of PRGF may be indicative of a lessened fiber to fiber hindrance; the addition of PRGF may mitigate some surface charge along the fibers during the electrospinning process, causing a higher density of fibers and subsequent decrease in pore area. These charge interactions vary dependent upon the polymer; 10 SF was the only scaffold that saw an increase in pore area upon the addition of PRGF and the other materials showed relatively consistent trends between concentrations. It has previously been demonstrated that fiber diameter plays a role in MAC activation and their secretion of proinflammatory molecules, where nanofibers have increased biocompatibility in comparison to microfibers [41] . Thus, the various diameters of these materials nanofibers are expected to have an affect on MAC activation. Ideal electrospun scaffolds for MAC M2 phenotype modification will have a larger pore area and increased fiber diameter (according to introduction). As electrospun scaffolds have already been demonstrated as promising for wound healing applications, the addition of PRGF does not significantly alter the structure of the scaffolds in a way that cannot be tailored for enhanced M2 activation.
(The scaffold materials and PRGF concentrations in this study are preliminary and are meant to show that it is possible not only to tailor the structure, especially with inclusion of PRGF, but also tailor the electrospinning process so the structure is consistent with an enhanced activation of M2 MACs.) AFM AFM was used to measure the elastic modulus of the fibers from all electrospun scaffolds. Figure 3 provides a visual of the AFM readings for all electrospun scaffolds, both dry and hydrated. Once measured, the average modulus (MPa) was found for all scaffolds (Figure 4 ). Note that al- Measure of fiber elastic modulus by AFM. Note that measurements were completed on both dry and hydrated fibers. *, &, andd enote a significant difference from 5 Gel, PCL, and SF. !, %, and # denote a significant difference from 5 Gel, PCL, and SF, all with PRGF. " and ? denote a significant difference from 15 PCL (+/− PRGF). / and < denote a significant difference from 10 SF (+/− PRGF) (p<0.05).
lowing the fibers to remain dry resulted in much more homogenously distributed results ( Figure 4A ). The modulus in the 5 Gel scaffold was significantly larger than 5 SF (+/− PRGF), 10 Gel (+/− PRGF), 15 PCL PRGF, and 10 SF (+/− PRGF). Additionally, 5 SF was significantly smaller than 5 Gel (+/− PRGF), 5 PCL (+/− PRGF), 15 PCL (+/− PRGF), and 10 SF (+/− PRGF). The addition of PRGF to 5 SF significantly lessened the modulus over the other scaffold material types. However, when hydrated the modulus values were not as homogenously distributed ( Figure 4B ). Ho-mogeneity in the dry scaffolds followed by high standard errors in hydrated samples may indicate regional variations in polymer density of the fibers, which when dry do not affect the polymer material properties but may cause microscale swelling and mechanical differences when hydrated. Modulus values for the 5 Gel fibers were significantly smaller than all scaffolds other than 10 Gel (+/− PRGF) and 10 Significant swelling and loss of contact occurred with hydration of the fibers, particularly in the gelatin scaffolds, which also showed a significantly lower modulus than hydrated regardless of PRGF inclusion; this effect is similar with the SF scaffolds. A non-significant but notable trend is noted in the reduction of modulus with hydration in 10 Gel and 5PCL, while other polymers had a very wide variance. This variance is most likely due to intermolecular variations in hydration and fiber structure; for example, the SF fibers appear to have thicker edges, indicating hollowness and therefore decreased modulus especially upon hydration. Gelatin fibers show the same lip, although less distinct. The trend in modulus decrease with hydration is more pronounced in higher concentration, indicating material properties and not PRGF incorporation. Gelatin and SF are polymers that typically have been known to swell; this is not necessarily detrimental to a wound healing scaffold and may enhance wound healing [42] [43] [44] .
(2) Biological Characterization of Electrospun Scaffolds Cell Infiltration
All electrospun scaffolds were seeded with MACs as previously described for 1, 4, and 7 days to determine the amount of infiltration into the various scaffold materials, dopants, and concentrations. Successful cell infiltration is necessary for tissue ingrowth as well as integration of the scaffold into the surrounding tissue [45] . Only images from day 1 and 7 are shown ( Figure 5 ). All plain concentrations of Gel did not yield cellular attachment or infiltration, except for 10 Gel on day 7. With the addition of PRGF, 5 Gel saw initial attachment on day 1 and some infiltration by day 7; 10 Gel with PRGF exhibited slight attachment by day 7. A small amount of cell attachment was shown with 15 PCL on day 1 and 5 PCL saw some cell attachment by day 7. In contrast, with the addition of PRGF both 5 and 15 PCL had cell attachment on day 1 and full infiltration by day 7. Both 5 and 10 SF showed minimal cell attachment on day 1, and 5 SF exhibited complete infiltration by day 7. With the addition of PRGF, 5 SF showed cell attachment by day 7 whereas 10 SF had cell attachment on day 1 and full infiltration by day 7. Overall, SF had the highest ability to fully infiltrate and retain cells over the 7-day time period. The addition of PRGF appears to provide a chemokinesis effect that enhances MAC migration into the scaffold. As the degree of cellular infiltration was so variable between scaffolds, quantitative analysis was not performed at this time. While electrospun scaffolds provide a structure similar to native extracellular matrix (ECM), it is necessary that the construct support and enhance cell infiltration and proliferation; proper cell infiltration allows cells to release anti-inflammatory cytokines to drive angiogenesis and break the chronic inflammation cycle. Infiltration of cells can only occur when the scaffold pores are of adequate size. Another factor in pore size is the allowance of multiple cells per pore to create blood vessels that will provide nutrients and further monocyte infiltration to the area, which will induce a more complete wound healing [46] . In addition to this, previous literature has supported that cell penetration and ECM deposition both increase with increasing fiber thickness; where smaller fibers can obstruct infiltration [47] [48] [49] . Higher fiber stiffness promotes cell attachment and proliferation, while an intermediate stiffness supports cell migration [50] . With the inclusion of a chemotactic dopant such as PRGF, infiltration can be enhanced, potentially lessening the healing time of the chronic wound; PRGF has been shown to signif- icantly reduce healing time in a chronic ulcer model when encapsulated within hydrogels [46] .
Cell Proliferation
HDFs were seeded using DMEM/F-12 and supplemented with SCM or CCM from each time point (days 1, 4, or 7) for 72 hours ( Figure 6 ). Overall, the SCM cell count remained around the control values, with a few exceptions ( Figure 6A ). Most importantly, the SCM from 5 SF PRGF day 7 scaffolds allowed for significantly more cell proliferation, than 5 SF day 1 and 7 SCM, day 1 control media, and 5 SF PRGF day 4 SCM. 5 SF PRGF day 1 SCM values were higher than 5 SF day 7. 5 PCL (+/− PRGF) day 7 SCM were significantly lower than day 4 and day 7 control media. 5 PCL PRGF day 4 SCM allowed for significantly more proliferation than 5 PCL (+/− PRGF) day 7 SCM. 5 Gel (+/− PRGF) day 7 SCM caused significantly less proliferation than 5 Gel (+/− PRGF) days 1 and 4 SCM. 5 Gel day 4 SCM were significantly more proliferative than day 1 control media. A general trend of this data shows that as scaffolds are exposed to media for longer time points, they allow for less proliferation. The exceptions to this rule are the PRGF doped scaffolds. As the scaffolds start to degrade they release growth factors found in the PRGF fibers which promote growth. Here, the CCM had previously been exposed to MACs for up to 7 days (1, 4, 7 days) before being applied to the hDF. While in general, days 1 and 4 were significantly lower than the controls, day 7 CCM appears to allow for proliferation similar to control media ( Figure 6B ). Therefore, initial exposure to CCM resulted in a large drop in cell number for all groups. 5 Gel (+/− PRGF), 5 PCL PRGF, and 15 PCL PRGF did not recover to control media levels. These four conditions were significantly lower than both the control media and 15 PCL CCM. 5 Gel (+/− PRGF) were significantly lower than 10 SF (+/− PRGF), 5 PCL, and 5 SF PRGF. Initially, as MACs are exposed to the scaffolds, they act in an M1 fashion releasing pro-inflammatory cytokines to remove the foreign object. By day 7, as scaffolds begin to break down, MACs convert to a proliferative phenotype allowing for fibroblast proliferation. These results are consistent with the VEGF release results, discussed below, where by day 7 MACs were releasing regenerative growth factors, such as VEGF.
Chemotaxis
The transwell assay was prepared and utilized as previously described to determine if the CCM or SCM creates a chemotactic gradient that induces migration of MACs towards the conditioned medias. After 7 days, percent chemotaxis was calculated ( Figure 7B ). 5 Gel SCM was significantly more chemotactic than 10 SF and 15 PCL (+/− PRGF). 5 Gel PRGF SCM was significantly more chemotactic than 5 SF, 10 SF, 15 PCL, and 5 PCL (+/− PRGF). 10 Gel SCM appears to be the most chemotactic where it was significantly more chemotactic than 5 SF, 10 SF, 5 PCL (+/− PRGF), and 15 PCL (+/− PRGF). In general, there was a slight increasing trend in chemotaxis for all material types with the inclusion of PRGF with the exception of 10 Gel. However, no significant differences were found between material types. This suggests that at later time points, the conditioned media did not initiate a chemotactic response and thus, was not affected by the various polymers. The PRGF showed a slightly increasing chemotacticity independent on scaffold material. This indicates that the addition of the PRGF does not hinder chemotaxis, nor do the various polymers used in the study.
VEGF Releasate
VEGF production in MACs was quantified to determine if MACs seeded on the scaffolds are induced toward an antiinflammatory M2 phenotype within the spectrum of MAC activation. MACs were seeded onto the scaffolds for 1, 4, and 7 days. Unseeded scaffolds were also placed in media for the same time points. Note that the controls consisted of solely DMEM/F-12 media, with and without cells. SCM and CCM were analyzed for the presence of VEGF (Table 2) . At day 1, the SCM had more VEGF present than the majority of the CCM. This was due to a large presence of VEGF immediately being extruded into the surrounding media from the scaffolds. However, over 4 and 7 days, the CCM exhibited higher concentrations of VEGF compared to SCM. This identifies that the macrophages are producing VEGF, supporting the conclusion that their phenotype was closer to M2 over time. Overall, PCL and SF (CCM) showed significantly higher concentrations of VEGF compared to their SCM counterparts, as well as both Gel CCM and SCM at day 7 (p<0.05). Note that this test was not conducted for 10 Gel as this scaffold proved difficult to fabricate and did not show advantages in early testing. Future work should examine cytokine expression similarly to that demonstrated in a previous study, providing more information on the releaste [41] . 
Angiogenesis
The effects of both 5 SF (+/− PRGF) CCM and SCM, as well as 15 PCL (+/− PRGF) CCM and SCM on tubule formation were analyzed (Figure 8 ). These scaffolds were chosen based on their previous cell infiltration and proliferation, as well as VEGF releasate data. Note that PCL yielded unrecognizable tube formation and is not included in the figure. While the CCM without PRGF showed the greatest early tube formation, the results were inconclusive as no single condition yielded quantifiable tube development and thus, image analysis could not be completed for this study. However, a trend of increased angiogenesis appears with higher tubule formation appearing in the CCM over the SCM, but with non-significant results. Future work will examine later time points, as previous testing identified higher quantities of VEGF, and utilize image analysis software to quantify tube formation as affected by these scaffolds.
Conclusion
This study provides a comprehensive evaluation of MAC phenotype in response to electropun scaffolds of varying material, fiber/pore diameter, fiber stiffness, and +/− the inclusion of PRP. It was hypothesized that a PRGF eluting electrospun scaffold would be capable of promoting the activation and subsequent phenotypic change of MACs towards an M2 lineage. It was found that increasing the polymer concentration in the electrospun solution, increased the diameter of the electrospun fibers, where increased fiber diameter has been shown to affect MAC activation and proinflammatory molecules. Upon incorporation of PRGF, the diameters remained consistent, but the majority of the pore areas decreased in size. The fiber stiffness as measured through AFM remained consistent across dry scaffolds. Once hydrated, 5 SF had the highest modulus and 10 SF PRGF the lowest. With respect to cell infiltration, PCL and SF had the highest degree of infiltration which was only increased upon the incorporation of PRGF. This is consistent with previous literature where increased stiffness yielded greater cellular infiltration. While MACs appeared to create a pro-inflammatory environment in retained media that hindered fibroblast growth, after 7 days the MACs converted to a more regenerative phenotype allowing for fibroblast proliferation. 5 and 15 PCL as well as 5 and 10 SF (both +/− PRGF) showed the highest proliferation. While 10 Gel SCM was the most chemotactic, all material types exhibited a slight increase in chemotaxis with the inclusion of PRGF. Additionally, in our study MACs that were exposed to scaffolds incorporated with PRGF showed an increased production of VEGF, a marker of tissue regeneration. Analysis of angiogenesis proved inconclusive, but data suggests that with CCM, there could be increased tube formation. Future work should examine a later time point where VEGF is present in larger quantities. The incorporation of PRGF into the scaffolds showed benefits including increased cell infiltration and the presence of VEGF. As SF exhibited excellent fiber and pore structure and cell properties upon the addition of PRGF, this scaffold was chosen as the most ideal structure for the creation of an off-theshelf dermal substitute. Future work should further identify macrophage phenotype change through the interaction with these scaffolds over time.
